And what about a cold or RSV? With all the illness spreading, it's virus soup out there these days. Some people feel so sick they're wondering if they're fighting more than one germ at once.
With COVID, flu and cold viruses spreading widely this winter, researchers looked into whether you can get infected with more than one at once.With COVID, flu and cold viruses spreading widely this winter, researchers looked into whether you can get infected with more than one at once.If you're like most Americans, someone in your family or social circle is sick right now with COVID, flu, a cold or RSV.
The risk for multiple infections is especially high this year because so many viruses have been surging together.It's unclear just how often this happens because most of the testing for this sort of thing is done on hospitalized patients, who probably aren't representative of the general public. But some studies have found co-infections in up to 20% of those patients.
That said, co-infections can occur at any age, especially among older people and others with weaker immune systems. who led the study."The children under two who has RSV were twice as likely to have severe illness compared to children who just had COVID and not RSV also."
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
COVID, RSV and the Flu: A Case of Viral Interference?The 'tripledemic' unfolding this winter is one of several odd trends among respiratory virus infections these last years. Viruses, it turns out, can block one another and take turns to dominate.
Leer más »
Moderna says RSV vaccine is 84% effective at preventing disease in older adultsRSV infections kill between 6,000 and 10,000 older adults every year and result in 60,000 to 120,000 hospitalizations, according to the CDC.
Leer más »
Moderna’s RSV Vaccine Reduces Risk of Respiratory Diseases, Study FindsAn RSV vaccine that Moderna is developing significantly reduced the risk of respiratory diseases in a key study, the company said
Leer más »
Moderna says RSV vaccine 84% effective at preventing symptoms in older adultsModerna Inc said on Tuesday that its experimental messenger RNA vaccine for respiratory syncytial virus (RSV) was 83.7% effective in a late-stage trial at preventing at least two symptoms, such as cough and fever, in adults aged 60 and older.
Leer más »
Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older AdultsAn RSV vaccine that Moderna is developing significantly reduced the risk of respiratory diseases in a key study, the company said
Leer más »